{
    "2021-12-17": [
        [
            {
                "time": "",
                "original_text": "天坛生物(600161.SH)：“注射用重组人凝血因子Ⅷ”取得临床试验总结报告",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "注射用重组人凝血因子Ⅷ",
                        "临床试验",
                        "总结报告"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "天坛生物：“注射用重组人凝血因子Ⅷ”和“静注人免疫球蛋白(pH4、10%) (层析法)”完成了Ⅲ期临床试验",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "注射用重组人凝血因子Ⅷ",
                        "静注人免疫球蛋白",
                        "Ⅲ期临床试验"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "天坛生物(600161.SH)：成都蓉生研制的“静注人免疫球蛋白(pH4、10%) (层析法)”完成了Ⅲ期临床试验并取得临床试验总结报告",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "成都蓉生",
                        "静注人免疫球蛋白",
                        "Ⅲ期临床试验",
                        "总结报告"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "天坛生物(600161.SH)：成都蓉生研制的“注射用重组人凝血因子Ⅷ”完成了Ⅲ期临床试验并取得临床试验总结报告",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "成都蓉生",
                        "注射用重组人凝血因子Ⅷ",
                        "Ⅲ期临床试验",
                        "总结报告"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "天坛生物(600161.SH)：所属浆站获得单采血浆许可证",
                "features": {
                    "keywords": [
                        "天坛生物",
                        "浆站",
                        "单采血浆许可证"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            }
        ]
    ]
}